Physician profile
Sanjay Batra
NPI 1114981917
$83,607.84
in general payments reported to CMS, 2019-2025
22 companies · $6,210 in 2025
The $6,210 reported for 2025 was more than what 85% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,564 · 2020: $1,529 · 2021: $24K · 2022: $34K · 2023: $5,005 · 2024: $7,723 · 2025: $6,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Travel and Lodging: $2,120 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,179.96 |
| Travel and Lodging | $2,119.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $637.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $63,975.17 | 2021-2025 | Corevalve Evolut R, Avalus, Apollotm |
| Atricure, INC. | $6,002.23 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System, Synergy Ablation System |
| Edwards Lifesciences Corporation | $5,182.79 | 2019-2025 | Mitris Resilia Mitral Valve, Konect Resilia, Carpentier-Edwards Physio Tricuspid Annuloplasty Ring |
| Medtronic Vascular, INC. | $3,824.87 | 2019-2020 | |
| Abiomed | $1,533.47 | 2022-2025 | Impella |
| Abbott Laboratories | $765.16 | 2021-2023 | Coroflow |
| Boston Scientific Corporation | $443.09 | 2019-2022 | |
| Artivion, INC. | $334.34 | 2019-2024 | Bioglue Surgical Adhesive, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Amds-Ascyrus Medical |
| Kestra Medical Technology Services, INC. | $307.22 | 2022-2025 | Assure Wcd |
| Chiesi USA, INC. | $201.87 | 2021 | |
| Getinge USA Sales, LLC | $183.28 | 2021-2025 | Vasoview Hemopro 2 |
| Terumo Cardiovascular Systems Corporation | $144.41 | 2019 | |
| Teleflex LLC | $141.35 | 2025 | Guideliner |
| Inari Medical, INC. | $132.83 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Access Systems, INC. | $117.83 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $114.71 | 2022 | |
| Lsi Solutions INC | $65.03 | 2022-2024 | Cor-Knot |
| Davol INC. | $55.04 | 2022 | |
| Ethicon INC. | $37.54 | 2024 | Monarch Platform |
| Zimmer Biomet Holdings, INC. | $23.14 | 2025 | Cable-Ready, Sternalock |
| Janssen Biotech, INC. | $22.47 | 2025 | Erleada |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Batra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.